Loading…
This Week in The Journal
Research suggests that a main symptom of attention-deficit/hyperactivity disorder (ADHD) is a disinclination to exert effort, even in the pursuit of a reward. However, the extent to which those with ADHD endure this impairment is not well known. Furthermore, whether the primary treatment for ADHD, a...
Saved in:
Published in: | The Journal of neuroscience 2023-10, Vol.43 (41), p.6831-6831 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Research suggests that a main symptom of attention-deficit/hyperactivity disorder (ADHD) is a disinclination to exert effort, even in the pursuit of a reward. However, the extent to which those with ADHD endure this impairment is not well known. Furthermore, whether the primary treatment for ADHD, amphetamine-based pharmaceuticals, improves diminished motivation is unknown. Chong et al measured the amount of cognitive and physical effort that 20 individuals with ADHD on and off people in a control group. They found that untreated individuals with ADHD had diminished motivation compared to control subjects, but amphetamine-based treatment increased the amount of cognitive and physical effort those with ADHD were willing to exert. Notably, treatment was so effective that most individuals with ADHD were motivated to a similar extent as those in the control group. These findings confirm that motivational deficit is a core trait of ADHD and demonstrate that it may be effectively targeted by the primary approved treatment for ADHD. Furthermore this work may inform future investigations into whether amphetamine-based treatments are effective for other disorders in which diminished motivation is a symptom. |
---|---|
ISSN: | 0270-6474 1529-2401 |
DOI: | 10.1523/JNEUROSCI.twij.43.41.2023 |